These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23948921)

  • 1. Augmentation of sensory-evoked hemodynamic response in an early Alzheimer's disease mouse model.
    Kim J; Jeong Y
    J Alzheimers Dis; 2013; 37(4):857-68. PubMed ID: 23948921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
    Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
    Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
    Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
    Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
    Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
    Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
    Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
    Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis.
    Princz-Kranz FL; Mueggler T; Knobloch M; Nitsch RM; Rudin M
    Neurobiol Dis; 2010 Oct; 40(1):284-92. PubMed ID: 20600914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6 T.
    Kara F; Dongen ES; Schliebs R; Buchem MA; Groot HJ; Alia A
    Neuroimage; 2012 Apr; 60(2):958-66. PubMed ID: 22227054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.
    Thal DR; Capetillo-Zarate E; Larionov S; Staufenbiel M; Zurbruegg S; Beckmann N
    Neurobiol Aging; 2009 Dec; 30(12):1936-48. PubMed ID: 18359131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E; Hölscher C
    J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
    Wu N; Rao X; Gao Y; Wang J; Xu F
    J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease.
    Takano T; Han X; Deane R; Zlokovic B; Nedergaard M
    Ann N Y Acad Sci; 2007 Feb; 1097():40-50. PubMed ID: 17413008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurovascular coupling preserved in a chronic mouse model of Alzheimer's disease: Methodology is critical.
    Sharp PS; Ameen-Ali KE; Boorman L; Harris S; Wharton S; Howarth C; Shabir O; Redgrave P; Berwick J
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2289-2303. PubMed ID: 31760864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbances in the control of capillary flow in an aged APP
    Gutiérrez-Jiménez E; Angleys H; Rasmussen PM; West MJ; Catalini L; Iversen NK; Jensen MS; Frische S; Østergaard L
    Neurobiol Aging; 2018 Feb; 62():82-94. PubMed ID: 29131981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression.
    Semar S; Klotz M; Letiembre M; Van Ginneken C; Braun A; Jost V; Bischof M; Lammers WJ; Liu Y; Fassbender K; Wyss-Coray T; Kirchhoff F; Schäfer KH
    J Alzheimers Dis; 2013; 36(1):7-20. PubMed ID: 23531500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility and variance of a stimulation-induced hemodynamic response in barrel cortex of awake behaving mice.
    Takuwa H; Autio J; Nakayama H; Matsuura T; Obata T; Okada E; Masamoto K; Kanno I
    Brain Res; 2011 Jan; 1369():103-11. PubMed ID: 21070750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
    de la Torre JC
    J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.